Stock News Releases and Press Releases OTCMKTS, NASDAQ and NYSE Markets

ARLO LAUNCHES STRATEGIC PARTNERSHIP WITH ALLSTATE PR Newswire Industry Leaders with Common Mission to Protect Customers Collaborate to Deliver Added Peace of Mind Through DIY Smart Home Security Solutions SAN JOSE, Calif. , July 2, 2024 /PRNewswire/ -- ...

BERKELEY, Calif. and MAINZ, Germany, July 02, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major accomplishments of the first six months ending June 30, 2024, and provided a cor...

WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has entered into a definitive agreement with a single healthcare-dedicated institutional in...

WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has entered into a definitive agreement with a single healthcare-dedicated institutional in...

2024-07-02 08:00:11 ET Gregory Francfort from Guggenheim issued a price target of $280.00 for MCD on 2024-07-02 07:03:00. The adjusted price target was set to $280.00. At the time of the announcement, MCD was trading at $249.99. The overall price target consensus is at $...

2024-07-02 08:00:11 ET Six Flags from Oppenheimer issued a price target of $67.00 for FUN on 2024-07-02 07:07:00. The adjusted price target was set to $67.00. At the time of the announcement, FUN was trading at $52.11. The overall price target consensus is at $51.11 with...

2024-07-02 08:00:10 ET Mark Astrachan from Stifel Nicolaus issued a price target of $71.00 for WMT on 2024-07-02 06:59:00. The adjusted price target was set to $71.00. At the time of the announcement, WMT was trading at $67.48. The overall price target consensus is at $1...

2024-07-02 08:00:10 ET Elyse Greenspan from Wells Fargo issued a price target of $287.00 for AON on 2024-07-02 06:50:00. The adjusted price target was set to $287.00. At the time of the announcement, AON was trading at $293.49. The overall price target consensus is at $3...

PHILADELPHIA, July 02, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced that Steven Nichtb...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that the Company has been added as a member of the broad-market Russell 3000 ® Index, effective after...